Background Neoadjuvant chemotherapy for advanced gallbladder cancer (GBC) has
recently been proposed as an alternative to adjuvant chemotherapy, with potential increase …

Background The benefit from chemotherapy, specifically for patients with gallbladder cancer
(GBC), has been poorly explored since GBC is mostly studied jointly with other biliary tract …

Importance Gallbladder cancer is uncommon but highly fatal. Surgery remains the only
potentially curative treatment for localized or locoregionally advanced gallbladder cancer …

Aims The aim of this study was to determine whether a combination of the tumour markers
carcinoembryonic (CEA) and carbohydrate antigen 19-9 (CA19-9) would be helpful in …

Gallbladder cancer (GBC) is one of the commonest biliary malignancies seen in India,
Argentina, and Japan. The disease has dismal outcome as it is detected quite late due to …

Gallbladder carcinoma (GBC) is among one of the gastrointestinal malignancies with
extremely dismal prognosis. This is due to the advanced stage at presentation. Majority of …

The neutrophil–lymphocyte ratio (NLR) is an immune response-related indicator and it is
associated with poor prognosis of various cancers. The carbohydrate antigen19-9 (CA19-9) …

Gallbladder cancer is the most common malignant cancer of the biliary tract and is distinct
from other forms of biliary tract cancer in several of its risk factors and molecular aberrations …

Background Recently for advanced gallbladder carcinoma, neoadjuvant chemotherapy has
emerged as an important strategy in place of adjuvant chemotherapy with the hope that it …

Gallbladder cancer (GBC) is a malignant tumor that originates from the mucosal lining of the
gallbladder. It is distinctly regional and is common in certain geographic regions of …